English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
- Recent progress in the management of pediatric chronic myeloid leukemia – Review
(Shima H and Shimada H. Int J Hematol, December 2022) (epub ahead of print) - Chronic myeloid leukemia in children: immune function and vaccinations
(Suttorp M et al. J Clin Med, September 2021) - open access publication - Management of pediatric leukemia (in French)
(Héritier S et al. Soins Pediatr Peuric, May-June 201) - Tyrosine kinase inhibitors and beyond for chronic myeloid leukemia in children
(Phillips LN and Hijiya N. Pediatr Drugs, May 2021) - Chronic myelogenous leukemia in childhood
(Smith SM et al. Curr Oncol Rep, March 2021) - Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia
Suttorp M et al. Cancers(Basel), February 2021 - open access publication - Features and outcomes of chronic myeloid leukemia at very young age:
Data from the International Pediatric Registry
(Meral Günes A et al. Pediatr Blood Cancer, January 2021) - Horn of plenty: Value of the International registry fore pediatric chronic myeloid leukemia
(Suttorp M et al. World J Clin Oncol, June 2020) - open access publication - How I treat chronic myeloid leukemia in children and adolescents
(Hijiya N and Suttorp M. Blood, May 2019) - open access publication - Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions
(Hijiya N et al. Pediatr Clin North Am, February 2016) - Chronic myeloid leukemia in children is a unique disease that requires a different approach
(Hijiya N et al. Blood, October 2015)
Meetings
-
- Dual T315I mutation F359I mutation positive pedia...
- In ICMLF Discussion / Clinical Case Discussion Forum
- 1 day 21 hours ago
-
- PAH during CML Therapy within clinical trial
- In ICMLF Discussion / Clinical Case Discussion Forum
- 2 weeks 4 days ago
-
Presentations from the EHA2022 Congress
-
EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)
-
EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)
-
COLT Meeting 2019: CML related topics
-
COLT Meeting 2019: The CML frontier
Review articles on pediatric CML
